FR2873691B1 - Derives d'amino-piperidine, leur preparation et leur application en therapeutique - Google Patents
Derives d'amino-piperidine, leur preparation et leur application en therapeutiqueInfo
- Publication number
- FR2873691B1 FR2873691B1 FR0408370A FR0408370A FR2873691B1 FR 2873691 B1 FR2873691 B1 FR 2873691B1 FR 0408370 A FR0408370 A FR 0408370A FR 0408370 A FR0408370 A FR 0408370A FR 2873691 B1 FR2873691 B1 FR 2873691B1
- Authority
- FR
- France
- Prior art keywords
- amino
- preparation
- therapeutic application
- piperidine derivatives
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408370A FR2873691B1 (fr) | 2004-07-29 | 2004-07-29 | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
EP05790800A EP1786809A2 (fr) | 2004-07-29 | 2005-07-20 | Derives d'amino-piperidine, leur preparation et leur application en tant qu'agonistes des recepteurs aux melanocortines |
JP2007523109A JP2008508241A (ja) | 2004-07-29 | 2005-07-20 | アミノピペリジン誘導体、その調製及びメラノコルチン受容体作用物質としてのその使用 |
CNA2005800292193A CN101039941A (zh) | 2004-07-29 | 2005-07-20 | 氨基哌啶衍生物及其制备方法和作为黑皮质素受体激动剂的用途 |
BRPI0512688-6A BRPI0512688A (pt) | 2004-07-29 | 2005-07-20 | derivados de amimo-piperidina, o respectivo preparo e a respectiva aplicação em terapêutica |
PCT/FR2005/001855 WO2006021656A2 (fr) | 2004-07-29 | 2005-07-20 | Derives d'amino- piperidine , leur preparation et leur application en tant qu'agonistes des recepteurs aux melanocortines |
MX2007001137A MX2007001137A (es) | 2004-07-29 | 2005-07-20 | Derivados de aminopiperidina, preparacion de los mismos y uso de los mismos como agonistas de receptor de melanocortina. |
KR1020077004659A KR20070047804A (ko) | 2004-07-29 | 2005-07-20 | 아미노피페리딘 유도체, 이의 제조 방법, 및 이의멜라노코르틴 수용체 효능제로서의 용도 |
AU2005276354A AU2005276354A1 (en) | 2004-07-29 | 2005-07-20 | Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
RU2007107375/04A RU2376303C2 (ru) | 2004-07-29 | 2005-07-20 | Производные аминопиперидина, их получение и применение в терапии |
CA002574454A CA2574454A1 (fr) | 2004-07-29 | 2005-07-20 | Derives d'amino- piperidine, leur preparation et leur application en therapeutique |
ARP050103111A AR050186A1 (es) | 2004-07-29 | 2005-07-27 | Derivados de amino-piperidina, su preparacion y su aplicacion en terapeutica. |
UY29041A UY29041A1 (es) | 2004-07-29 | 2005-07-28 | Derivados de amino-piperidina, su preparacion y su utilización en terapeutica |
TW094125586A TW200621768A (en) | 2004-07-29 | 2005-07-28 | Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
PE2005000890A PE20060562A1 (es) | 2004-07-29 | 2005-08-01 | Derivados de amino-piperidina como agonistas de los receptores de melanocortina mc3 y/o mc4 |
IL180766A IL180766A (en) | 2004-07-29 | 2007-01-17 | Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
US11/626,972 US20070191364A1 (en) | 2004-07-29 | 2007-01-25 | Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408370A FR2873691B1 (fr) | 2004-07-29 | 2004-07-29 | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2873691A1 FR2873691A1 (fr) | 2006-02-03 |
FR2873691B1 true FR2873691B1 (fr) | 2006-10-06 |
Family
ID=34949116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0408370A Expired - Fee Related FR2873691B1 (fr) | 2004-07-29 | 2004-07-29 | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070191364A1 (fr) |
EP (1) | EP1786809A2 (fr) |
JP (1) | JP2008508241A (fr) |
KR (1) | KR20070047804A (fr) |
CN (1) | CN101039941A (fr) |
AR (1) | AR050186A1 (fr) |
AU (1) | AU2005276354A1 (fr) |
BR (1) | BRPI0512688A (fr) |
CA (1) | CA2574454A1 (fr) |
FR (1) | FR2873691B1 (fr) |
IL (1) | IL180766A (fr) |
MX (1) | MX2007001137A (fr) |
PE (1) | PE20060562A1 (fr) |
RU (1) | RU2376303C2 (fr) |
TW (1) | TW200621768A (fr) |
UY (1) | UY29041A1 (fr) |
WO (1) | WO2006021656A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873690B1 (fr) * | 2004-07-29 | 2006-10-13 | Sanofi Synthelabo | Derives d'oxopiperidine, leur preparation et leur application en therapeutique |
PL2474545T3 (pl) | 2005-12-13 | 2017-04-28 | Incyte Holdings Corporation | Podstawione heteroarylem pirolo[2,3-b]pirydyny i pirolo[2,3-b]pirymidyny jako inhibitory kinazy Janusowej |
US8044068B2 (en) | 2006-04-04 | 2011-10-25 | Taisho Pharmaceutical Co., Ltd | Aminopyrrolidine compound |
HUE043732T2 (hu) | 2007-06-13 | 2019-09-30 | Incyte Holdings Corp | Januskináz gátló hatású (R)-3-(4-(7H pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciklopentilpropánnitril sók alkalmazása |
WO2010065800A1 (fr) * | 2008-12-04 | 2010-06-10 | Palatin Technologies, Inc. | Composés de pipérazine spécifiques des récepteurs de la mélanocortine substitués par un hydrazine |
AU2010249380B2 (en) * | 2009-05-22 | 2015-08-20 | Incyte Holdings Corporation | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors |
CA2761954C (fr) | 2009-05-22 | 2018-07-31 | Incyte Corporation | 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- ou heptane-nitrile en tant qu'inhibiteurs de jak |
TW201113285A (en) | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
AR081315A1 (es) * | 2010-03-10 | 2012-08-08 | Incyte Corp | Derivados heterociclicos de piperidin y pirimidin -4-il-azetidina, una forma cristalina de la sal del acido acetonitriladipico de un derivado pirimidinico, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades relacionadas con la inhibicion de jak-1, t |
NZ603686A (en) | 2010-05-21 | 2014-11-28 | Incyte Corp | Topical formulation for a jak inhibitor |
EA026201B1 (ru) | 2010-11-19 | 2017-03-31 | Инсайт Холдингс Корпорейшн | Циклобутилзамещенные производные пирролопиридина и пирролопиримидина как ингибиторы jak |
JP5917544B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン |
AR086983A1 (es) | 2011-06-20 | 2014-02-05 | Incyte Corp | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
UA111854C2 (uk) * | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
KR20130083592A (ko) * | 2012-01-13 | 2013-07-23 | 현대약품 주식회사 | 치환된 피페리딘 유도체 및 이의 제조방법 |
AR091079A1 (es) | 2012-05-18 | 2014-12-30 | Incyte Corp | Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak |
PL2919766T3 (pl) | 2012-11-15 | 2021-10-04 | Incyte Holdings Corporation | Postacie dawkowania ruksolitynibu o przedłużonym uwalnianiu |
AU2014225938B2 (en) | 2013-03-06 | 2018-07-19 | Incyte Holdings Corporation | Processes and intermediates for making a JAK inhibitor |
MX2016001639A (es) | 2013-08-07 | 2016-10-07 | Incyte Corp | Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1). |
WO2015184305A1 (fr) | 2014-05-30 | 2015-12-03 | Incyte Corporation | Traitement de la leucémie neutrophile chronique (cnl) et de la leucémie myéloïde chronique atypique (acml) par des inhibiteurs de jak1 |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
DK3746429T3 (da) | 2018-01-30 | 2022-05-02 | Incyte Corp | Fremgangsmåder til fremstilling af (1-(3-fluor-2-(trifluormethyl)isonicotinyl)piperidin-4-on) |
GB201801562D0 (en) | 2018-01-31 | 2018-03-14 | Almac Diagnostics Ltd | Pharmaceutical compounds |
UA127925C2 (uk) | 2018-03-30 | 2024-02-14 | Інсайт Корпорейшн | Лікування гнійного гідраденіту з використанням інгібіторів jak |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968929A (en) * | 1996-10-30 | 1999-10-19 | Schering Corporation | Piperazino derivatives as neurokinin antagonists |
EP1187614A4 (fr) * | 1999-06-04 | 2005-06-22 | Merck & Co Inc | Piperidines substituees en tant qu'agonistes du recepteur de melanocortine-4 |
EP1268449A4 (fr) * | 2000-03-23 | 2004-09-15 | Merck & Co Inc | Piperidines substituees en tant qu'agonistes du recepteur de la melanocortine |
EP1363631A4 (fr) * | 2001-03-02 | 2005-11-16 | Bristol Myers Squibb Co | Composes utiles comme modulateurs des recepteurs de la melanocortine et compositions pharmaceutiques renfermant ceux-ci |
US6977264B2 (en) * | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
US7049323B2 (en) * | 2003-04-25 | 2006-05-23 | Bristol-Myers Squibb Company | Amidoheterocycles as modulators of the melanocortin-4 receptor |
WO2005047251A1 (fr) * | 2003-11-12 | 2005-05-26 | Lg Life Sciences Ltd. | Agonistes du recepteur de la melanocortine |
FR2873690B1 (fr) * | 2004-07-29 | 2006-10-13 | Sanofi Synthelabo | Derives d'oxopiperidine, leur preparation et leur application en therapeutique |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
-
2004
- 2004-07-29 FR FR0408370A patent/FR2873691B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-20 CN CNA2005800292193A patent/CN101039941A/zh active Pending
- 2005-07-20 KR KR1020077004659A patent/KR20070047804A/ko not_active Application Discontinuation
- 2005-07-20 JP JP2007523109A patent/JP2008508241A/ja active Pending
- 2005-07-20 BR BRPI0512688-6A patent/BRPI0512688A/pt not_active IP Right Cessation
- 2005-07-20 AU AU2005276354A patent/AU2005276354A1/en not_active Abandoned
- 2005-07-20 CA CA002574454A patent/CA2574454A1/fr not_active Abandoned
- 2005-07-20 RU RU2007107375/04A patent/RU2376303C2/ru not_active IP Right Cessation
- 2005-07-20 EP EP05790800A patent/EP1786809A2/fr not_active Withdrawn
- 2005-07-20 MX MX2007001137A patent/MX2007001137A/es active IP Right Grant
- 2005-07-20 WO PCT/FR2005/001855 patent/WO2006021656A2/fr active Application Filing
- 2005-07-27 AR ARP050103111A patent/AR050186A1/es not_active Application Discontinuation
- 2005-07-28 TW TW094125586A patent/TW200621768A/zh unknown
- 2005-07-28 UY UY29041A patent/UY29041A1/es not_active Application Discontinuation
- 2005-08-01 PE PE2005000890A patent/PE20060562A1/es not_active Application Discontinuation
-
2007
- 2007-01-17 IL IL180766A patent/IL180766A/en not_active IP Right Cessation
- 2007-01-25 US US11/626,972 patent/US20070191364A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2574454A1 (fr) | 2006-03-02 |
AR050186A1 (es) | 2006-10-04 |
EP1786809A2 (fr) | 2007-05-23 |
FR2873691A1 (fr) | 2006-02-03 |
CN101039941A (zh) | 2007-09-19 |
TW200621768A (en) | 2006-07-01 |
IL180766A0 (en) | 2007-06-03 |
US20070191364A1 (en) | 2007-08-16 |
BRPI0512688A (pt) | 2008-04-01 |
MX2007001137A (es) | 2007-04-19 |
WO2006021656A2 (fr) | 2006-03-02 |
IL180766A (en) | 2011-10-31 |
WO2006021656A3 (fr) | 2006-06-08 |
RU2007107375A (ru) | 2008-09-10 |
JP2008508241A (ja) | 2008-03-21 |
UY29041A1 (es) | 2006-02-24 |
KR20070047804A (ko) | 2007-05-07 |
PE20060562A1 (es) | 2006-07-12 |
RU2376303C2 (ru) | 2009-12-20 |
AU2005276354A1 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2873691B1 (fr) | Derives d'amino-piperidine, leur preparation et leur application en therapeutique | |
MA28734B1 (fr) | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique | |
MA28575B1 (fr) | Derives de la 1-amino-phthalazine, leur preparation , et leur application en therapeutique | |
FR2854158B1 (fr) | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique | |
MA28343A1 (fr) | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique | |
FR2864080B1 (fr) | Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique | |
FR2882054B1 (fr) | Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique | |
FR2854633B1 (fr) | Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique | |
FR2866884B1 (fr) | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique | |
MA29017B1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
MA27049A1 (fr) | Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique | |
FR2866888B1 (fr) | Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique | |
FR2843964B1 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
FR2885364B1 (fr) | Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique | |
FR2888847B1 (fr) | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique | |
MA28720B1 (fr) | Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique | |
FR2891828B1 (fr) | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique | |
FR2850377B1 (fr) | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique | |
MA27233A1 (fr) | Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique | |
FR2866885B1 (fr) | Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique | |
FR2856684B1 (fr) | Derives de diphenylpyridine, leur preparation et leur application en therapeutique | |
FR2864958B1 (fr) | Derive de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique. | |
FR2891825B1 (fr) | Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique | |
FR2873690B1 (fr) | Derives d'oxopiperidine, leur preparation et leur application en therapeutique | |
FR2887548B1 (fr) | Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CD | Change of name or company name | ||
ST | Notification of lapse |
Effective date: 20130329 |